The price certainly has plenty of catching up to do.I guess that when the first results from the trial are announced the price will more than double.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025